Wellington Management Group LLP Theravance Biopharma, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 191,329 shares of TBPH stock, worth $1.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

191,329

Previous 350,587 45.43%

Holding current value

$1.88 Million

Previous $2.97 Million 48.12%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.66 - $10.25 $1.22 Million - $1.63 Million	-159,258 Reduced 45.43%	191,329 $1.54 Million
Q2 2024 Aug 13, 2024	BUY	$8.29 - $9.92 $162,691 - $194,680	19,625 Added 5.93%	350,587 $2.97 Million
Q1 2024 May 15, 2024	BUY	$8.22 - $11.59 $2.72 Million - $3.84 Million	330,962 New	330,962 $2.97 Million
Q4 2023 Feb 12, 2024	BUY	$8.58 - $11.4 $2.46 Million - $3.27 Million	287,102 New	287,102 $3.23 Million
Q3 2023 Nov 14, 2023	SELL	$8.38 - $10.44 $94,878 - $118,201	-11,322 Reduced 6.21%	170,938 $1.48 Million
Q2 2023 Aug 14, 2023	BUY	$10.16 - $11.92 $426,709 - $500,628	41,999 Added 29.94%	182,260 $1.89 Million
Q1 2023 May 12, 2023	SELL	$9.87 - $11.44 $31,297 - $36,276	-3,171 Reduced 2.21%	140,261 $1.52 Million
Q4 2022 Feb 13, 2023	SELL	$9.65 - $11.34 $77,952 - $91,604	-8,078 Reduced 5.33%	143,432 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $33,912 - $41,309	4,042 Added 2.74%	151,510 $1.54 Million
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $7,728 - $9,502	-919 Reduced 0.62%	147,468 $1.34 Million
Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $413,726 - $643,684	-49,667 Reduced 25.08%	148,387 $1.42 Million
Q4 2021 Feb 11, 2022	SELL	$7.42 - $11.05 $387,064 - $576,423	-52,165 Reduced 20.85%	198,054 $2.19 Million
Q3 2021 Nov 15, 2021	SELL	$6.77 - $14.41 $57.4 Million - $122 Million	-8,477,105 Reduced 97.13%	250,219 $1.85 Million
Q2 2021 Aug 16, 2021	BUY	$14.52 - $22.46 $18.3 Million - $28.4 Million	1,263,122 Added 16.92%	8,727,324 $127 Million
Q1 2021 May 17, 2021	BUY	$16.57 - $21.08 $33.1 Million - $42.1 Million	1,996,902 Added 36.52%	7,464,202 $152 Million
Q4 2020 Feb 12, 2021	BUY	$14.89 - $20.16 $11 Million - $14.9 Million	739,708 Added 15.65%	5,467,300 $97.2 Million
Q3 2020 Nov 16, 2020	BUY	$14.79 - $22.49 $3.62 Million - $5.51 Million	244,815 Added 5.46%	4,727,592 $69.9 Million
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $6.51 Million - $9.68 Million	315,254 Added 7.56%	4,482,777 $94.1 Million
Q1 2020 May 14, 2020	BUY	$17.84 - $31.21 $17.7 Million - $30.9 Million	989,986 Added 31.16%	4,167,523 $96.3 Million
Q4 2019 Feb 11, 2020	BUY	$16.12 - $25.89 $51.2 Million - $82.3 Million	3,177,537 New	3,177,537 $82.3 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Theravance Biopharma, Inc. Transaction History